Appendix cancer, once rare, is now rising sharply among younger people. Firstpost brings out an expert’s views on the risk ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Jenna Scott said doctors chalked up her abdominal cramping to pregnancy symptoms or IBS. It took a year to get diagnosed with ...

In an interview with CURE, Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for gastrointestinal cancers and how they might impact a ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment approaches. Gastrointestinal Stromal Tumors: GISTs Diagnosis & Treatment - Los ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes ...

A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

Compared with people born from 1941 through 1949, incidence rates of appendix cancer have more than tripled among people born ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.